Objectives To analyze the oncological and functional outcomes of patients with stage III-IV laryngo-hypopharyngeal cancer who underwent neoadjuvant chemotherapy (NAC) with …
Purpose To analyze the oncological outcomes and patterns of recurrence of patients with locoregionally advanced oropharyngeal squamous cell carcinoma (OPSCC) who underwent …
YM Park, CM Jung, D Cha, DH Kim, HR Kim… - Annals of surgical …, 2017 - Springer
Background A prospective clinical trial of combination neoadjuvant chemotherapy, transoral robotic surgery (TORS), and customized adjuvant therapy for patients with locally advanced …
YM Park, KC Keum, HR Kim, BC Cho, DH Kim… - Annals of surgical …, 2018 - Springer
Background We conducted a prospective clinical trial of combination neoadjuvant chemotherapy, transoral robotic surgery (TORS), and customized adjuvant therapy in …
EJ Moore, KM Van Abel, DL Price, CM Lohse… - Head & …, 2018 - Wiley Online Library
Background This study presents oncologic outcomes after transoral robotic surgery (TORS)±adjuvant therapy for oropharyngeal squamous cell carcinoma (SCC). Methods …
E Gordin - Annals of Surgical Oncology, 2018 - Springer
The treatment of head and neck cancer has long stood on the three pillars of surgery, chemotherapy and radiation. While the indications for and timing of administration of these …
CC Wang, WJ Lin, YC Liu, CC Chen, SH Wu… - Journal of Clinical …, 2021 - mdpi.com
Transoral robotic surgery (TORS) has been used for treating pharyngeal and laryngeal cancers for many years. However, the application of neoadjuvant chemotherapy (NACT) …
B Dhanireddy, NP Burnett, S Sanampudi… - American Journal of …, 2019 - Elsevier
Purpose Optimal treatment strategies for the management of oropharyngeal squamous cell carcinoma (OPSCC) remain unclear. The objective of this study is to examine the role of …
Objectives/Hypothesis To assess adjuvant therapy in patients undergoing surgical management of oropharyngeal squamous cell carcinoma (OPSCCA) with transoral robotic …